Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Oct 21, 2020
Date Accepted: Jan 9, 2021

The final, peer-reviewed published version of this preprint can be found here:

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

Narimatsu H, Sato A, Haneda E, Suganuma N

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

JMIR Form Res 2021;5(2):e25184

DOI: 10.2196/25184

PMID: 33544084

PMCID: 7895643

Preliminary Screening for Hereditary Breast and Ovarian Cancer using a Chatbot Augmented Intelligence Genetic Counselor

  • Hiroto Narimatsu; 
  • Ann Sato; 
  • Eri Haneda; 
  • Nobuyasu Suganuma

ABSTRACT

Background:

Breast cancer is the most common form of cancer in Japan; genetic background and hereditary breast and ovarian cancer (HBOC) are implicated. The key to HBOC diagnosis involves screening to identify high-risk individuals. However, genetic medicine is still developing, thus, many patients who may potentially benefit from genetic medicine have not yet been identified.

Objective:

To develop a chatbot system that used augmented intelligence for HBOC screening to determine whether patients meet the National Comprehensive Cancer Network (NCCN) BRCA1/2 testing criteria.

Methods:

The system was evaluated by a specialist doctor in genetic medicine and certified genetic counselors. We prepared three scenarios and created a conversation with the chatbot to reflect each. The chatbot feasibility, the time required, the medical accuracy of conversations and family history, and the final result were evaluated.

Results:

The times required for the conversation were 7 minutes for scenario 1, 15 minutes for scenario 2, and 16 minutes for scenario 3. Scenarios 1 and 2 met the BRCA1/2 testing criteria, while scenario 3 did not, and this result was consistent with the findings of three experts who retrospectively reviewed conversations with the chatbot according to the three scenarios. A family history comparison ascertained by the chatbot with the actual scenarios revealed that each result was consistent with each scenario. From a genetic medicine perspective, no errors were noted by the three experts.

Conclusions:

This study demonstrated that chatbot systems can be applied to the preliminary genetic medicine screening for HBOC.


 Citation

Please cite as:

Narimatsu H, Sato A, Haneda E, Suganuma N

Preliminary Screening for Hereditary Breast and Ovarian Cancer Using a Chatbot Augmented Intelligence Genetic Counselor: Development and Feasibility Study

JMIR Form Res 2021;5(2):e25184

DOI: 10.2196/25184

PMID: 33544084

PMCID: 7895643

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.